Eden Research (LON:EDEN) Stock Price Down 3.3% – Time to Sell?

Posted by Terry King on Feb 22nd, 2025

Eden Research plc (LON:EDEN – Get Free Report) shares fell 3.3% on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The stock has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The firm’s 50 day moving average is GBX 3.88 and its two-hundred day moving average is GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey acquired 540,540 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). 14.02% of the stock is owned by company insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.